Filtered By:
Condition: Cholesterol
Procedure: Percutaneous Coronary Intervention
This page shows you your search results in order of date. This is page number 8.
Order by Relevance | Date
Total 160 results found since Jan 2013.
Epicardial adipose tissue volume predicts long term major adverse cardiovascular events in patients with Type 2 diabetes
CONCLUSION: EAT volume is an independent predictor of long-term MACE in patients with T2-DM without previous coronary events. EAT volume may be used additionally in risk stratification for MACE besides the well-known vascular risk factors in patients with T2-DM.PMID:33709918 | DOI:10.5543/tkda.2021.65635
Source: Turk Kardiyoloji Dernegi arsivi - March 12, 2021 Category: Cardiology Authors: Beg üm Uygur Ömer Çelik Ali R ıza Demir Muammer Karakayal ı Çağdaş Arslan Hafize Otcu Temur Deniz Alis Ceren Y ıldırım B üşra Çörekçioğlu Mehmet Ert ürk Source Type: research
Safety and Efficacy of Perioperative Use of Evolocumab in Myocardial Infarction Patients: Study Protocol for a Multicentre Randomized Controlled Trial
This study aims to evaluate the safety and efficacy of this treatment regimen.MethodsA multicentre, prospective, randomized, controlled superiority trial will be conducted in 530 statin-na ïve MI patients. All eligible patients will be randomized to the evolocumab group (140 mg subcutaneously injected once before revascularization + 14 days after the first dose) or the control group (no evolocumab injection). Evolocumab will then be administered depending on the patient's lipid profile. Both groups will be treated simultaneously with standardized secondary preventive medications. The primary end points are major adv...
Source: Advances in Therapy - February 27, 2021 Category: Drugs & Pharmacology Source Type: research
